These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12596357)

  • 1. The increasing importance of genetic variation in drug discovery and development.
    Labaudinière R
    Curr Opin Mol Ther; 2002 Dec; 4(6):559-64. PubMed ID: 12596357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics in drug discovery: the best things come to those who wait.
    Bansal AT; Barnes MR
    Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of osteoporosis: opportunities and challenges.
    Nguyen TV; Eisman JA
    J Musculoskelet Neuronal Interact; 2006; 6(1):62-72. PubMed ID: 16675890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of whole-genome association scans in disease gene identification, drug discovery and development.
    Roses AD; St Jean PL; Ehm MG
    IDrugs; 2007 Nov; 10(11):797-804. PubMed ID: 17968762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific target selection: a critical first step down the right road.
    Roses AD; Burns DK; Chissoe S; Middleton L; St Jean P
    Drug Discov Today; 2005 Feb; 10(3):177-89. PubMed ID: 15708532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
    Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
    Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational approaches to natural-product-based drug design.
    Haustedt LO; Mang C; Siems K; Schiewe H
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):445-62. PubMed ID: 16889228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rational approach to maximize success rate in target discovery.
    Schneider M
    Arch Pharm (Weinheim); 2004 Dec; 337(12):625-33. PubMed ID: 15597396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics in breast cancer: current trends and future directions.
    Wajapeyee N; Somasundaram K
    Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical biomarkers in drug discovery and development.
    Frank R; Hargreaves R
    Nat Rev Drug Discov; 2003 Jul; 2(7):566-80. PubMed ID: 12838269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepigenetics: its role in interindividual differences in drug response.
    Gomez A; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2009 Apr; 85(4):426-30. PubMed ID: 19242404
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of BacMam virus gene delivery technology in a drug discovery setting.
    Kost TA; Condreay JP; Ames RS; Rees S; Romanos MA
    Drug Discov Today; 2007 May; 12(9-10):396-403. PubMed ID: 17467576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia.
    Williams M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):31-6. PubMed ID: 12625025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?
    Lango H; Weedon MN
    J Intern Med; 2008 Jan; 263(1):16-27. PubMed ID: 18088250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.